Browsing Tag
biotech earnings
2 posts
Compass Pathways fast-tracks COMP360 launch timeline as Q3 2025 results show improved financial runway
Learn how Compass Pathways’ faster COMP360 launch timeline after Q3 2025 results could reshape the psychedelics industry and investor sentiment.
Amgen reports strong Q4 growth amid expanding product sales and biotech innovations
Amgen’s revenue growth for the fourth quarter of 2024 exceeded analyst expectations, reflecting the company’s expanding biopharmaceutical portfolio…